Welcome to
Allurion’s
Newsroom

Filter by language : AR / EN / ES / FR / IT
July 11, 2017

This Company Raised $27 Million for a Weight Loss Balloon You Can Swallow in a Pill

FORTUNE – Beyond diet and exercise, Americans who need to lose significant weight—whether to guard against diabetes, heart disease, or other obesity-related illnesses—don’t have a lot of ideal options. Bariatric surgery is invasive, risky, and expensive.

July 11, 2017

Allurion Raises $27 Million for Weight-Loss Tech

WSJ – Startup’s balloon-based system delivers weight loss without surgery

May 18, 2017

Swallowable gastric balloon could help the obese lose weight without surgery

THE GUARDIAN – Although not a replacement for bariatric surgery, temporary balloon could be used as early intervention or for those who do not want, or cannot have, surgery

April 7, 2017

VIDEO – Allurion co-founder Shantanu Gaur presents at SAGES 2016

March 31, 2017

Allurion Repays Massachusetts Life Sciences Center

MLSC – The Massachusetts Life Sciences Center (MLSC) and Natick-based Allurion Technologies announced that the company, which was awarded a $750,000 Accelerator loan from the MLSC in 2011, has repaid the loan with interest after a successful funding round from private investors.

March 1, 2017

VIDEO – Blue Mirror – Interview with Allurion co-founder Samuel Levy

START-UP FOOD

February 12, 2017

VIDEO – Balloon You Can Swallow Fights Obesity

NBC NEWS

February 7, 2017

More Data on Balloon-in-a-Pill Show Almost 15% Weight Loss

MEDSCAPE – Results from another small trial with a novel intragastric balloon that can be swallowed without the patient requiring endoscopy or anesthesia show that the 42 participants lost an average of 15.6 kg (34 lb), or over 14% of their body weight, over the 16-week duration of the trial.

The patients involved in the study had an average BMI of 38.6 kg/mat the start of the study and in this case were put on a ketogenic, very low-calorie diet (700 kcal/day) diet for the last 4 weeks of the trial.

February 7, 2017

Number To Know…10

MEDTECH INSIGHT – 10 minutes is the time it takes to prep the non-surgical, ingestible Elipse gastric balloon for obesity treatment. Elipse is developed by Allurion Technologies, which just bagged $19m in new funding.

January 4, 2017

21 intriguing new ideas and trailblazing people

BOSTON GLOBE – Free college for Boston students, an Alzheimer’s hope, weight loss in an (inflatable) pill, and more.